These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2223577)

  • 1. HAB-1, a new heteromyeloma for continuous production of human monoclonal antibodies.
    Faller G; Vollmers HP; Weiglein I; Marx A; Zink C; Pfaff M; Müller-Hermelink HK
    Br J Cancer; 1990 Oct; 62(4):595-8. PubMed ID: 2223577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
    Gustafsson B; Jondal M; Sundqvist VA
    Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of heteromyeloma fusion partners which promote the outgrowth of porcine hybridomas.
    Greenlee AR; Magnuson NS; Smith C; Butt BM; McKiernan AJ; Davis WC
    Vet Immunol Immunopathol; 1990 Nov; 26(3):267-83. PubMed ID: 2264287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
    Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
    Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
    J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
    Teng NN; Lam KS; Calvo Riera F; Kaplan HS
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies in the development of human monoclonal antibodies.
    Jahn S; Grunow R; Kiessig ST; Settmacher U; Von Baehr R
    Dev Biol Stand; 1990; 71():3-7. PubMed ID: 2401386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
    Seifert M; Jahn S; Schwab J; Döcke W; Volk HD; von Baehr R
    Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
    Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
    Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
    [No Abstract]   [Full Text] [Related]  

  • 11. The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus.
    Grunow R; Jahn S; Porstmann T; Kiessig SS; Steinkellner H; Steindl F; Mattanovich D; Gürtler L; Deinhardt F; Katinger H
    J Immunol Methods; 1988 Feb; 106(2):257-65. PubMed ID: 2828478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Karyotypic characteristics of a number of clonal lines of an interspecific mouse-mink hybridoma].
    Glazko TT
    Tsitologiia; 1988 May; 30(5):597-605. PubMed ID: 3176172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonals against erythrocyte antigens.
    Ernst M; Sonneborn HH
    Hum Antibodies Hybridomas; 1990; 1(3):122-5. PubMed ID: 1966475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New heteromyeloma cell lines for the production of human monoclonal antibodies.
    Zanella I; Verardi R; Negrini R; Poiesi C; Ghielmi S; Albertini A
    J Immunol Methods; 1992 Dec; 156(2):205-15. PubMed ID: 1335463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
    Glaser RW; Jahn S; Grunow R
    Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
    Kalantarov GF; Rudchenko SA; Lobel L; Trakht I
    Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas.
    Thompson KM; Melamed MD; Eagle K; Gorick BD; Gibson T; Holburn AM; Hughes-Jones NC
    Immunology; 1986 May; 58(1):157-60. PubMed ID: 3011653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.